Development, validation, and application of an LC–MS/MS method for the quantification of the novel antibiotic drug lefamulin (Xenleta®) and its main metabolite 2R-hydroxy lefamulin in human plasma
| Autor: | Strickmann, Dirk B., Faber, Jörg, Klaassen, Tobias |
|---|---|
| Zdroj: | In Journal of Pharmaceutical and Biomedical Analysis 25 October 2021 205 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect